FDA Amends Monograph for OTC Nasal Decongestant Drug Products to Include Levmetamfetamine

Summary

The FDA is updating the regulations for over-the-counter nasal decongestant medications by adding levmetamfetamine, a new ingredient, and removing another ingredient, l-desoxyephedrine, from the list of approved active ingredients, as part of its ongoing review of OTC medications.